158th EB Individual Statements
Esteemed delegates and Honorable Chairperson,
On behalf of medical students and young health professionals worldwide, IFMSA expresses concern regarding the threat posed by substandard and falsified medical products. These products not only jeopardise patient safety but also compromise treatment effectiveness and worsen antimicrobial resistance, particularly in LMICs, where regulatory procedures and supply chain oversight may lack.
Tackling this challenge requires robust regulatory systems, quality assurance protocols, and comprehensive pharmacovigilance mechanisms. It is imperative that equitable access to safe medicines is prioritised.
We further highlight the role of youth and young physicians in combating this global issue. Through health education and meaningful advocacy, medical students can raise awareness about the dangers, support safe prescribing practices, and contribute to national pharmacovigilance initiatives.
Thank you.
Contact person: Sie Meng Lee, Liaison Officer to the World health Organization - lwho@ifmsa.org